Alpha Teknova, Inc.

Alpha Teknova, Inc. (ticker: TKNO) is an NASDAQ-listed in vitro & in vivo diagnostic substances company. DredgeCap's structured extraction of TKNO's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. TKNO reported $11.08M in revenue and -$4.55M for the period ending 2026-03-31, with operating cash flow of -$3.36M. Cash and equivalents stood at $4.31M (up 27.5% year-over-year). Total assets of $98.66M exceed total liabilities of $33.73M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.